Halis Kaan Akturk MD
Diabetes, Lipid Metabolism
Associate professor of medicine and pediatrics
Join to View Full Profile
Barbara Davis Center for DiabetesAurora, CO 80045
Dr. Akturk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Halis Akturk is an endocrinologist in Aurora, CO and is affiliated with University of Colorado Hospital. He received his medical degree from Istanbul University Faculty of Medicine and has been in practice 10 years. He also speaks multiple languages, including Turkish and German. He is experienced in type i diabetes mellitus, tumor immunotherapy, insulin pump management, type ii diabetes, and continuous glucose monitoring.
Education & Training
Mayo Clinic College of Medicine and Science (Jacksonville)Fellowship, Endocrinology, Diabetes, and Metabolism, 2016
Creighton University School of Medicine (Omaha)Residency, Internal Medicine, 2011 - 2014
Istanbul University FomClass of 2007
Certifications & Licensure
CO State Medical License 2016 - 2025
FL State Medical License 2014 - 2018
NE State Medical License Active through 2013
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Young Internists of 2011 European Federation of Internal Medicine, 2011
Publications & Presentations
PubMed
- Flying With Type 1 Diabetes as Commercial Airline Pilots in the U.S.: The Sky Is the Limit for People With Type 1 Diabetes.Kagan Ege Karakus, Emma Mason, Halis Kaan Akturk
Diabetes Care. 2025-04-01 - Seeing the Road Ahead-The Need to Address Accessibility of Diabetes Technology.Rishika Kartik, Halis Kaan Akturk, Michael W Stewart, Gregory P Forlenza
Diabetes Technology & Therapeutics. 2025-04-01 - Control-IQ Technology Provides Similar Glycemic Outcomes Across Two Different CGM Sensors.Halis Kaan Akturk, Andy K Johnson, John B Welsh, Laurel H Messer
Journal of Diabetes Science and Technology. 2025-03-31
Journal Articles
- PD-1 Inhibitor Immune-Related Adverse Events in Patients with Preexisting Endocrine AutoimmunityHalis Kaan Akturk, Aaron W Michels, The Journal of Clinical Endocrinology and Metabolism
- The Cortisol Stress Response Induced by Surgery: A Systematic Review and Meta‐AnalysisHalis Kaan Akturk, Irina Bancos, Clinical Endocrinology
- Linagliptin for the treatment of Type 2 diabetesTella SH, Akturk HK, Rendell M, Diabetes Management, 2014
Authored Content
- Highlights in ADA 2022 for Diabetes Technologies and TherapeuticsJune 2022
- Highlights in ADA 2021 for Diabetes Technologies and TherapeuticsJuly 2021
Press Mentions
Q&A: How Adults with Type 1 Diabetes Can Become Commercial Airline PilotsMarch 17th, 2025
Pot Use Tied to Serious Diabetes ComplicationNovember 8th, 2018
Additional Positive Afrezza® Clinical Data from STAT Study to Be Presented at ADA 78th Scientific SessionsJune 25th, 2018- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
- Member
- Member
Other Languages
- Turkish, German
External Links
- Akraba Evliligi( Consanguineous marriages and autosomal recessive disorders)http://www.akrabaevliligi.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
